Remington G - Search Results

1

Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.

Zai CC, Hwang RW, De Luca V, Müller DJ, King N, Zai GC, Remington G, Meltzer HY, Lieberman JA, Potkin SG, Kennedy JL. Zai CC, et al. Among authors: remington g. Int J Neuropsychopharmacol. 2007 Oct;10(5):639-51. doi: 10.1017/S1461145706007152. Epub 2006 Sep 7. Int J Neuropsychopharmacol. 2007. PMID: 16959057 Free article.

2

Relationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effects.

Tugg LA, Desai D, Prendergast P, Remington G, Reed K, Zipursky RB. Tugg LA, et al. Among authors: remington g. Schizophr Res. 1997 May 3;25(1):71-8. doi: 10.1016/s0920-9964(97)00009-1. Schizophr Res. 1997. PMID: 9176929

3

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.

Kapur S, Zipursky R, Jones C, Remington G, Houle S. Kapur S, et al. Among authors: remington g. Am J Psychiatry. 2000 Apr;157(4):514-20. doi: 10.1176/appi.ajp.157.4.514. Am J Psychiatry. 2000. PMID: 10739409 Clinical Trial.

4

Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the bench.

Kapur S, Wadenberg ML, Remington G. Kapur S, et al. Among authors: remington g. Can J Psychiatry. 2000 Apr;45(3):241-6. doi: 10.1177/070674370004500302. Can J Psychiatry. 2000. PMID: 10779880 Review.

5

Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study.

Silvestri S, Seeman MV, Negrete JC, Houle S, Shammi CM, Remington GJ, Kapur S, Zipursky RB, Wilson AA, Christensen BK, Seeman P. Silvestri S, et al. Among authors: remington gj. Psychopharmacology (Berl). 2000 Oct;152(2):174-80. doi: 10.1007/s002130000532. Psychopharmacology (Berl). 2000. PMID: 11057521

6

Awareness of tardive dyskinesia in Asian patients with schizophrenia.

Chong SA, Remington G, Mahendran R, Chua HC. Chong SA, et al. Among authors: remington g. J Clin Psychopharmacol. 2001 Apr;21(2):235-7. doi: 10.1097/00004714-200104000-00017. J Clin Psychopharmacol. 2001. PMID: 11270922

7

The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy?

Turrone P, Remington G, Nobrega JN. Turrone P, et al. Among authors: remington g. Neurosci Biobehav Rev. 2002 May;26(3):361-80. doi: 10.1016/s0149-7634(02)00008-8. Neurosci Biobehav Rev. 2002. PMID: 12034136 Review.

8

Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats.

Turrone P, Remington G, Kapur S, Nobrega JN. Turrone P, et al. Among authors: remington g. Neuropsychopharmacology. 2003 Aug;28(8):1433-9. doi: 10.1038/sj.npp.1300233. Epub 2003 Jul 2. Neuropsychopharmacology. 2003. PMID: 12838271

9

Understanding antipsychotic "atypicality": a clinical and pharmacological moving target.

Remington G. Remington G. J Psychiatry Neurosci. 2003 Jul;28(4):275-84. J Psychiatry Neurosci. 2003. PMID: 12921222 Free PMC article. Review.

10

A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone.

Mamo D, Kapur S, Shammi CM, Papatheodorou G, Mann S, Therrien F, Remington G. Mamo D, et al. Among authors: remington g. Am J Psychiatry. 2004 May;161(5):818-25. doi: 10.1176/appi.ajp.161.5.818. Am J Psychiatry. 2004. PMID: 15121646 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

544 results

Search Page

Filters